These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12851107)

  • 1. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate.
    Kramer JA; Blomme EA; Bunch RT; Davila JC; Jackson CJ; Jones PF; Kolaja KL; Curtiss SW
    Toxicol Pathol; 2003; 31(4):417-31. PubMed ID: 12851107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.
    Nesfield SR; Clarke CJ; Hoivik DJ; Miller RT; Allen JS; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):301-11. PubMed ID: 16257850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Savina PM; Santostefano MJ
    Int J Toxicol; 2005; 24(5):313-25. PubMed ID: 16257851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
    Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
    Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.
    Nesfield SR; Williams TC; Hoivik DJ; Miller RT; Allen JS; Selinger K; Rickert D; Santostefano MJ
    Int J Toxicol; 2005; 24(5):341-8. PubMed ID: 16257853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators.
    Tamura K; Ono A; Miyagishima T; Nagao T; Urushidani T
    J Toxicol Sci; 2006 Dec; 31(5):471-90. PubMed ID: 17202761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.
    Torrey CE; Campbell JA; Hoivik DJ; Miller RT; Allen JS; Mann PC; Selinger K; Rickert D; Savina PM; Santostefano MJ
    Int J Toxicol; 2005; 24(5):289-99. PubMed ID: 16257849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents.
    Luci S; Giemsa B; Hause G; Kluge H; Eder K
    BMC Pharmacol; 2007 Apr; 7():6. PubMed ID: 17437637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays.
    Baker VA; Harries HM; Waring JF; Duggan CM; Ni HA; Jolly RA; Yoon LW; De Souza AT; Schmid JE; Brown RH; Ulrich RG; Rockett JC
    Environ Health Perspect; 2004 Mar; 112(4):428-38. PubMed ID: 15033592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of pyrazinamide and clofibrate on gene expression of rat hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme of the tryptophan-NAD pathway.
    Egashira Y; Sato M; Sato M; Sugawara R; Tanabe A; Shin M; Sanada H
    Int J Vitam Nutr Res; 2006 May; 76(3):138-46. PubMed ID: 17048193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha (PPAR alpha) agonist, WY-14,643, increased transcription of myosin light chain-2 in cardiomyocytes.
    Hamano T; Kobayashi K; Sakairi T; Hayashi M; Mutai M
    J Toxicol Sci; 2001 Dec; 26(5):275-84. PubMed ID: 11871124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.
    Moffit JS; Koza-Taylor PH; Holland RD; Thibodeau MS; Beger RD; Lawton MP; Manautou JE
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):169-79. PubMed ID: 17585979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats.
    Kim SC; Hong JT; Jang SJ; Kang WS; Yoo HS; Yun YP
    J Toxicol Sci; 1998 May; 23(2):113-9. PubMed ID: 9644651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver.
    McMillian M; Nie AY; Parker JB; Leone A; Kemmerer M; Bryant S; Herlich J; Yieh L; Bittner A; Liu X; Wan J; Johnson MD
    Biochem Pharmacol; 2004 Jun; 67(11):2141-65. PubMed ID: 15135310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
    Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
    Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
    Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
    Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analysis of peroxisome proliferators- and phenytoin-induced hepatotoxicity using cDNA microarray.
    Jung JW; Park JS; Hwang JW; Kang KS; Lee YS; Song BS; Lee GJ; Yeo CD; Kang JS; Lee WS; Jeon KS; Um CH; Kim YS; Oh MJ; Youn JP; Li P; Park JE; Hwang SY
    J Vet Med Sci; 2004 Nov; 66(11):1329-33. PubMed ID: 15585944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis reveals chemical-specific profiles.
    Hamadeh HK; Bushel PR; Jayadev S; Martin K; DiSorbo O; Sieber S; Bennett L; Tennant R; Stoll R; Barrett JC; Blanchard K; Paules RS; Afshari CA
    Toxicol Sci; 2002 Jun; 67(2):219-31. PubMed ID: 12011481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.